tissue microarray (tma) images (Human Protein Atlas)
90
Structured Review
Human Protein Atlas
tissue microarray (tma) images
Tissue Microarray (Tma) Images, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tissue+microarray+(tma)+images/tissue+microarray+staining+result/pm39704929-43-14-22
Average 90 stars, based on 1 article reviews
Tissue Microarray (Tma) Images, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tissue+microarray+(tma)+images/tissue+microarray+staining+result/pm39704929-43-14-22
Average 90 stars, based on 1 article reviews
tissue microarray (tma) images - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Expressing:Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Article Title: TissueWiki Mobile : an Integrative Protein Expression Image Browser for Pathological Knowledge Sharing and Annotation on a Mobile Device Article Snippet: The Article Title: Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non-small cell lung cancer. Article Snippet: Department of Life Science, Chung‐Ang University, Seoul, Republic of Korea Correspondence Sangmyung Rhee, Department of Life Science, Chung‐Ang University, Seoul 06974, Republic of Korea.. Email: sangmyung.rhee@cau.ac.kr Funding information National Research Foundation of Korea; Chung‐Ang University Graduate Research Scholarship; Korea Environment Industry & Technology Institute (KEITI) Matrix stiffness has been shown to play a critical role in cancer progression by influencing various cellular processes, including epidermal growth factor (EGF) signaling.. However, the underlying molecular mechanisms are not fully understood. Article Title: CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma. Article Snippet: in approximately 15% of LUAD patients.. To address this, EGFR-tyrosine kinases inhibitors (TKIs), which selectively inhibit EGFR activity, have been developed and are continually refined.. Starting with first-generation EGFR-TKIs, such as erlotinib and gefitinib, the Food and Drug Administration has now approved the third-generation EGFR-TKI, osimertinib for clinical use (Cooper et al. 2022). Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Staining:Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Article Title: TissueWiki Mobile : an Integrative Protein Expression Image Browser for Pathological Knowledge Sharing and Annotation on a Mobile Device Article Snippet: The Article Title: Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non-small cell lung cancer. Article Snippet: Department of Life Science, Chung‐Ang University, Seoul, Republic of Korea Correspondence Sangmyung Rhee, Department of Life Science, Chung‐Ang University, Seoul 06974, Republic of Korea.. Email: sangmyung.rhee@cau.ac.kr Funding information National Research Foundation of Korea; Chung‐Ang University Graduate Research Scholarship; Korea Environment Industry & Technology Institute (KEITI) Matrix stiffness has been shown to play a critical role in cancer progression by influencing various cellular processes, including epidermal growth factor (EGF) signaling.. However, the underlying molecular mechanisms are not fully understood. Article Title: CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma. Article Snippet: in approximately 15% of LUAD patients.. To address this, EGFR-tyrosine kinases inhibitors (TKIs), which selectively inhibit EGFR activity, have been developed and are continually refined.. Starting with first-generation EGFR-TKIs, such as erlotinib and gefitinib, the Food and Drug Administration has now approved the third-generation EGFR-TKI, osimertinib for clinical use (Cooper et al. 2022). Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Microarray:Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Article Title: TissueWiki Mobile : an Integrative Protein Expression Image Browser for Pathological Knowledge Sharing and Annotation on a Mobile Device Article Snippet: The Article Title: Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non-small cell lung cancer. Article Snippet: Department of Life Science, Chung‐Ang University, Seoul, Republic of Korea Correspondence Sangmyung Rhee, Department of Life Science, Chung‐Ang University, Seoul 06974, Republic of Korea.. Email: sangmyung.rhee@cau.ac.kr Funding information National Research Foundation of Korea; Chung‐Ang University Graduate Research Scholarship; Korea Environment Industry & Technology Institute (KEITI) Matrix stiffness has been shown to play a critical role in cancer progression by influencing various cellular processes, including epidermal growth factor (EGF) signaling.. However, the underlying molecular mechanisms are not fully understood. Article Title: CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma. Article Snippet: in approximately 15% of LUAD patients.. To address this, EGFR-tyrosine kinases inhibitors (TKIs), which selectively inhibit EGFR activity, have been developed and are continually refined.. Starting with first-generation EGFR-TKIs, such as erlotinib and gefitinib, the Food and Drug Administration has now approved the third-generation EGFR-TKI, osimertinib for clinical use (Cooper et al. 2022). Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Immunohistochemistry:Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Article Title: TissueWiki Mobile : an Integrative Protein Expression Image Browser for Pathological Knowledge Sharing and Annotation on a Mobile Device Article Snippet: The Article Title: Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non-small cell lung cancer. Article Snippet: Department of Life Science, Chung‐Ang University, Seoul, Republic of Korea Correspondence Sangmyung Rhee, Department of Life Science, Chung‐Ang University, Seoul 06974, Republic of Korea.. Email: sangmyung.rhee@cau.ac.kr Funding information National Research Foundation of Korea; Chung‐Ang University Graduate Research Scholarship; Korea Environment Industry & Technology Institute (KEITI) Matrix stiffness has been shown to play a critical role in cancer progression by influencing various cellular processes, including epidermal growth factor (EGF) signaling.. However, the underlying molecular mechanisms are not fully understood. Article Title: CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma. Article Snippet: in approximately 15% of LUAD patients.. To address this, EGFR-tyrosine kinases inhibitors (TKIs), which selectively inhibit EGFR activity, have been developed and are continually refined.. Starting with first-generation EGFR-TKIs, such as erlotinib and gefitinib, the Food and Drug Administration has now approved the third-generation EGFR-TKI, osimertinib for clinical use (Cooper et al. 2022). Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Labeling:Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: Article Title: TissueWiki Mobile : an Integrative Protein Expression Image Browser for Pathological Knowledge Sharing and Annotation on a Mobile Device Article Snippet: The Article Title: Downregulation of AP1S1 causes the lysosomal degradation of EGFR in non-small cell lung cancer. Article Snippet: Department of Life Science, Chung‐Ang University, Seoul, Republic of Korea Correspondence Sangmyung Rhee, Department of Life Science, Chung‐Ang University, Seoul 06974, Republic of Korea.. Email: sangmyung.rhee@cau.ac.kr Funding information National Research Foundation of Korea; Chung‐Ang University Graduate Research Scholarship; Korea Environment Industry & Technology Institute (KEITI) Matrix stiffness has been shown to play a critical role in cancer progression by influencing various cellular processes, including epidermal growth factor (EGF) signaling.. However, the underlying molecular mechanisms are not fully understood. Article Title: CKAP4 is a potential therapeutic target to overcome resistance to EGFR-TKIs in lung adenocarcinoma. Article Snippet: in approximately 15% of LUAD patients.. To address this, EGFR-tyrosine kinases inhibitors (TKIs), which selectively inhibit EGFR activity, have been developed and are continually refined.. Starting with first-generation EGFR-TKIs, such as erlotinib and gefitinib, the Food and Drug Administration has now approved the third-generation EGFR-TKI, osimertinib for clinical use (Cooper et al. 2022). Article Title: CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker Article Snippet: |